NDC 47783-646 – Takhzyro
Lanadelumab 300 mg/2mL · Solution · Subcutaneous
Product NDC47783-646
Product details
- Brand name
- Takhzyro
- Generic name
- Lanadelumab-flyo
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761090
- Marketed since
- February 8, 2022
- Listing expires
- December 31, 2027
- Pharmacologic class
- Plasma Kallikrein Inhibitor
Active ingredients
- Lanadelumab 300 mg/2mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 47783-646-01 | 1 SYRINGE, GLASS in 1 CARTON (47783-646-01) / 2 mL in 1 SYRINGE, GLASS | Feb 8, 2022 |
Other Takhzyro products
- 47783-645 Lanadelumab 150 mg/mL · Solution · Takeda Pharmaceuticals America, Inc.